Rate My Professor Kent Stewart

At High Point University since 2015, Stewart teaches chemistry lecture and laboratory courses, emphasizing the three-dimensional atomic structures of medicines. His academic interests center on medicinal chemistry and computer-aided structure-based drug design to discover novel compounds with bioactivity against proteases, kinases, DNA-binding agents, and viruses including HIV, influenza, and hepatitis C. Key publications encompass Kempf et al., 'ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans' (Proc. Natl. Acad. Sci. USA, 1995); Stoll et al., 'X-ray crystallographic structure of ABT-378 (Lopinavir) bound to HIV-1 protease' (Bioorg. Med. Chem., 2002); Wang et al., 'Design, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores' (J. Med. Chem., 2001); and Pei et al., 'Discovery, structure-activity relationship, and pharmacological evaluation of... dipeptidyl peptidase IV inhibitors' (J. Med. Chem., 2006). Stewart received the 2024 American Chemical Society Heroes of Chemistry Award for his Rinvoq team contributions, was named Professor of the Year by HPU pharmacy students in 2019, and delivered a seminar on computer-aided drug design at Johns Hopkins University in 2024.